Dyslipidemia, one of the hallmarks of metabolic syndrome, is characterized by decreased levels of HDL cholesterol and increased levels of triglycerides (TG), apo B, and small dense LDL cholesterol particles. This evidence concerns the gene APOB and metabolic syndrome.